TNF Pharmaceuticals (TNFA) Competitors $0.14 -0.02 (-10.57%) Closing price 04:00 PM EasternExtended Trading$0.13 0.00 (-2.92%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock TNFA vs. ORGS, CYCN, GNPX, KPRX, ACXP, BCLI, BMRA, CARM, SLXN, and ADXNShould you be buying TNF Pharmaceuticals stock or one of its competitors? The main competitors of TNF Pharmaceuticals include Orgenesis (ORGS), Cyclerion Therapeutics (CYCN), Genprex (GNPX), Kiora Pharmaceuticals (KPRX), Acurx Pharmaceuticals (ACXP), Brainstorm Cell Therapeutics (BCLI), Biomerica (BMRA), Carisma Therapeutics (CARM), Silexion Therapeutics (SLXN), and Addex Therapeutics (ADXN). These companies are all part of the "pharmaceutical products" industry. TNF Pharmaceuticals vs. Its Competitors Orgenesis Cyclerion Therapeutics Genprex Kiora Pharmaceuticals Acurx Pharmaceuticals Brainstorm Cell Therapeutics Biomerica Carisma Therapeutics Silexion Therapeutics Addex Therapeutics Orgenesis (NASDAQ:ORGS) and TNF Pharmaceuticals (NASDAQ:TNFA) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their media sentiment, valuation, community ranking, analyst recommendations, institutional ownership, dividends, profitability, earnings and risk. Which has higher earnings and valuation, ORGS or TNFA? TNF Pharmaceuticals has lower revenue, but higher earnings than Orgenesis. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrgenesis$662K14.14-$55.36MN/AN/ATNF PharmaceuticalsN/AN/A-$4M-$6.67-0.02 Does the MarketBeat Community favor ORGS or TNFA? Orgenesis received 1 more outperform votes than TNF Pharmaceuticals when rated by MarketBeat users. CompanyUnderperformOutperformOrgenesisOutperform Votes1100.00% Underperform VotesNo VotesTNF PharmaceuticalsN/AN/A Does the media favor ORGS or TNFA? In the previous week, TNF Pharmaceuticals had 1 more articles in the media than Orgenesis. MarketBeat recorded 1 mentions for TNF Pharmaceuticals and 0 mentions for Orgenesis. TNF Pharmaceuticals' average media sentiment score of 1.89 beat Orgenesis' score of 0.00 indicating that TNF Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Orgenesis Neutral TNF Pharmaceuticals Very Positive Do insiders and institutionals hold more shares of ORGS or TNFA? 22.6% of Orgenesis shares are owned by institutional investors. Comparatively, 9.6% of TNF Pharmaceuticals shares are owned by institutional investors. 5.7% of Orgenesis shares are owned by insiders. Comparatively, 0.5% of TNF Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Which has more volatility and risk, ORGS or TNFA? Orgenesis has a beta of 0.54, indicating that its share price is 46% less volatile than the S&P 500. Comparatively, TNF Pharmaceuticals has a beta of 2.06, indicating that its share price is 106% more volatile than the S&P 500. Is ORGS or TNFA more profitable? TNF Pharmaceuticals has a net margin of 0.00% compared to Orgenesis' net margin of -3,827.81%. Orgenesis' return on equity of 0.00% beat TNF Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Orgenesis-3,827.81% N/A -130.18% TNF Pharmaceuticals N/A -180.71%-84.27% SummaryTNF Pharmaceuticals beats Orgenesis on 6 of the 11 factors compared between the two stocks. Get TNF Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TNFA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TNFA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TNFA vs. The Competition Export to ExcelMetricTNF PharmaceuticalsDiagnostic substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.94M$2.68B$5.58B$8.50BDividend YieldN/A0.70%5.28%4.17%P/E Ratio-0.027.7427.1919.64Price / SalesN/A35.24408.78152.17Price / CashN/A15.7538.3234.64Price / Book0.025.416.974.60Net Income-$4M-$65.73M$3.23B$248.06M7 Day Performance-18.45%-3.80%-0.88%-1.02%1 Month Performance-23.34%-0.50%7.81%3.51%1 Year PerformanceN/A-21.63%31.53%12.68% TNF Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TNFATNF PharmaceuticalsN/A$0.14-10.6%N/AN/A$1.94MN/A-0.026Gap DownHigh Trading VolumeORGSOrgenesis1.5526 of 5 stars$1.95+0.4%N/AN/A$9.35M$662K0.00150Gap UpCYCNCyclerion Therapeutics1.8793 of 5 stars$2.96+5.3%N/A+36.6%$9.02M$2.08M-2.5530GNPXGenprex1.4685 of 5 stars$0.32-4.4%N/A-87.7%$8.88MN/A0.0020Short Interest ↑KPRXKiora Pharmaceuticals3.1405 of 5 stars$2.91-2.3%$10.00+243.6%-37.4%$8.86M$16M-1.0010Short Interest ↓ACXPAcurx Pharmaceuticals3.2402 of 5 stars$0.38-2.9%$8.00+2,020.9%-86.7%$8.86MN/A-0.353Gap UpBCLIBrainstorm Cell Therapeutics3.9749 of 5 stars$1.11-0.9%$30.00+2,602.7%-82.7%$8.81MN/A-0.2340Short Interest ↑BMRABiomerica0.317 of 5 stars$3.39+11.1%N/A-28.4%$8.63M$5.68M-9.9760Positive NewsShort Interest ↑CARMCarisma Therapeutics3.3146 of 5 stars$0.20+4.9%$1.93+862.5%-53.1%$8.36M$19.96M-0.1320SLXNSilexion TherapeuticsN/A$0.96-7.7%$5.00+420.8%N/A$8.34MN/A0.00N/AUpcoming EarningsADXNAddex Therapeutics2.5014 of 5 stars$7.79-2.9%$30.00+285.1%-4.6%$8.26M$404.10K-22.9130Positive NewsGap Up Related Companies and Tools Related Companies Orgenesis Alternatives Cyclerion Therapeutics Alternatives Genprex Alternatives Kiora Pharmaceuticals Alternatives Acurx Pharmaceuticals Alternatives Brainstorm Cell Therapeutics Alternatives Biomerica Alternatives Carisma Therapeutics Alternatives Silexion Therapeutics Alternatives Addex Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TNFA) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWe’ve Entered the Most Bullish Phase of the CycleIt happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TNF Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TNF Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
